3 Interindividual variability and precision response: host factors governing SFN bioavailability and efficacy The journey of SFN from dietary intake to systemic bioactivity is a complex process governed by a series of metabolic conversions and, crucially, modulated by significant inter-individual variation
Enhance Antioxidant Enzymes: Neutralizing the oxidative stress that leads to sagging
Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T,
535 p53 can accelerate ferroptosis and the development of atherosclerosis by binding to SLC7A11, preventing the synthesis of GSH, and increasing the hydrolysis of GSH and the production of ROS by activating glutaminase 2
Toxins: 3-5 days onset, 14-day final